Which has better earnings & valuation, VCYT or OMDA?

Veracyte has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veracyte $541.74M 7.36 $66.35M $1.09 45.82 Omada Health $260.21M 4.16 -$12.78M -$0.27 N/A

Is VCYT or OMDA more profitable?

Veracyte has a net margin of 16.25% compared to Omada Health's net margin of -2.22%. Veracyte's return on equity of 9.07% beat Omada Health's return on equity. Company Net Margins Return on Equity Return on Assets Veracyte 16.25% 9.07% 8.38% Omada Health -2.22% -1.82% -1.36%

Does the media prefer VCYT or OMDA?

In the previous week, Veracyte had 20 more articles in the media than Omada Health. MarketBeat recorded 22 mentions for Veracyte and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat Veracyte's score of 0.43 indicating that Omada Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 6 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Omada Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to OMDA or OPCH?

In the previous week, Option Care Health had 9 more articles in the media than Omada Health. MarketBeat recorded 11 mentions for Option Care Health and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat Option Care Health's score of 1.03 indicating that Omada Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer OMDA or CON?

In the previous week, Concentra Group Holdings Parent had 1 more articles in the media than Omada Health. MarketBeat recorded 3 mentions for Concentra Group Holdings Parent and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat Concentra Group Holdings Parent's score of 0.56 indicating that Omada Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Concentra Group Holdings Parent 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, OMDA or GRAL?

Omada Health has higher revenue and earnings than GRAIL. Omada Health is trading at a lower price-to-earnings ratio than GRAIL, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Omada Health $260.21M 4.16 -$12.78M -$0.27 N/A GRAIL $147.17M 19.41 -$408.35M -$10.37 N/A

Is OMDA or GRAL more profitable?

Omada Health has a net margin of -2.22% compared to GRAIL's net margin of -253.22%. Omada Health's return on equity of -1.82% beat GRAIL's return on equity. Company Net Margins Return on Equity Return on Assets Omada Health -2.22% -1.82% -1.36% GRAIL -253.22% -16.42% -14.34%

Does the media prefer OMDA or GRAL?

In the previous week, GRAIL had 13 more articles in the media than Omada Health. MarketBeat recorded 15 mentions for GRAIL and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat GRAIL's score of 0.18 indicating that Omada Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive GRAIL 1 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media prefer OMDA or LFST?

In the previous week, LifeStance Health Group had 2 more articles in the media than Omada Health. MarketBeat recorded 4 mentions for LifeStance Health Group and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat LifeStance Health Group's score of 0.96 indicating that Omada Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Omada Health (OMDA) Competitors

$18.21 +0.88 (+5.08%)

Closing price 06/4/2026 04:00 PM Eastern

Extended Trading

$18.14 -0.07 (-0.36%)

As of 05:13 AM Eastern

Compare

OMDA vs. VCYT, OPCH, CON, GRAL, and LFST

Should you buy Omada Health stock or one of its competitors? MarketBeat compares Omada Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Omada Health include Veracyte (VCYT), Option Care Health (OPCH), Concentra Group Holdings Parent (CON), GRAIL (GRAL), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.

How does Omada Health compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Omada Health (NASDAQ:OMDA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

In the previous week, Veracyte had 20 more articles in the media than Omada Health. MarketBeat recorded 22 mentions for Veracyte and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat Veracyte's score of 0.43 indicating that Omada Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	6 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
Omada Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Veracyte has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$541.74M	7.36	$66.35M	$1.09	45.82
Omada Health	$260.21M	4.16	-$12.78M	-$0.27	N/A

Veracyte currently has a consensus target price of $47.57, indicating a potential downside of 4.74%. Omada Health has a consensus target price of $22.91, indicating a potential upside of 25.81%. Given Omada Health's stronger consensus rating and higher probable upside, analysts clearly believe Omada Health is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69

Veracyte has a net margin of 16.25% compared to Omada Health's net margin of -2.22%. Veracyte's return on equity of 9.07% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
Omada Health	-2.22%	-1.82%	-1.36%

Summary

Veracyte beats Omada Health on 10 of the 14 factors compared between the two stocks.

How does Omada Health compare to Option Care Health?

Omada Health (NASDAQ:OMDA) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Option Care Health has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	4.16	-$12.78M	-$0.27	N/A
Option Care Health	$5.65B	0.56	$207.59M	$1.29	15.56

Option Care Health has a net margin of 3.64% compared to Omada Health's net margin of -2.22%. Option Care Health's return on equity of 18.17% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
Option Care Health	3.64%	18.17%	7.16%

In the previous week, Option Care Health had 9 more articles in the media than Omada Health. MarketBeat recorded 11 mentions for Option Care Health and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat Option Care Health's score of 1.03 indicating that Omada Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Option Care Health	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.1% of Option Care Health shares are held by institutional investors. 6.4% of Omada Health shares are held by insiders. Comparatively, 1.7% of Option Care Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Omada Health presently has a consensus target price of $22.91, suggesting a potential upside of 25.81%. Option Care Health has a consensus target price of $31.25, suggesting a potential upside of 55.71%. Given Option Care Health's higher probable upside, analysts clearly believe Option Care Health is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Option Care Health	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.69

Summary

Option Care Health beats Omada Health on 11 of the 15 factors compared between the two stocks.

How does Omada Health compare to Concentra Group Holdings Parent?

Omada Health (NASDAQ:OMDA) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Concentra Group Holdings Parent has a net margin of 7.97% compared to Omada Health's net margin of -2.22%. Concentra Group Holdings Parent's return on equity of 47.14% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
Concentra Group Holdings Parent	7.97%	47.14%	6.48%

Concentra Group Holdings Parent has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	4.16	-$12.78M	-$0.27	N/A
Concentra Group Holdings Parent	$2.23B	1.43	$166.41M	$1.39	17.97

Omada Health currently has a consensus price target of $22.91, suggesting a potential upside of 25.81%. Concentra Group Holdings Parent has a consensus price target of $30.25, suggesting a potential upside of 21.08%. Given Omada Health's higher possible upside, analysts plainly believe Omada Health is more favorable than Concentra Group Holdings Parent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Concentra Group Holdings Parent	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Concentra Group Holdings Parent had 1 more articles in the media than Omada Health. MarketBeat recorded 3 mentions for Concentra Group Holdings Parent and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat Concentra Group Holdings Parent's score of 0.56 indicating that Omada Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Concentra Group Holdings Parent	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Concentra Group Holdings Parent beats Omada Health on 9 of the 13 factors compared between the two stocks.

How does Omada Health compare to GRAIL?

Omada Health (NASDAQ:OMDA) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Omada Health currently has a consensus target price of $22.91, indicating a potential upside of 25.81%. GRAIL has a consensus target price of $67.88, indicating a potential upside of 1.99%. Given Omada Health's stronger consensus rating and higher possible upside, research analysts plainly believe Omada Health is more favorable than GRAIL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
GRAIL	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30

Omada Health has higher revenue and earnings than GRAIL. Omada Health is trading at a lower price-to-earnings ratio than GRAIL, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	4.16	-$12.78M	-$0.27	N/A
GRAIL	$147.17M	19.41	-$408.35M	-$10.37	N/A

Omada Health has a net margin of -2.22% compared to GRAIL's net margin of -253.22%. Omada Health's return on equity of -1.82% beat GRAIL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
GRAIL	-253.22%	-16.42%	-14.34%

In the previous week, GRAIL had 13 more articles in the media than Omada Health. MarketBeat recorded 15 mentions for GRAIL and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat GRAIL's score of 0.18 indicating that Omada Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
GRAIL	1 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Omada Health beats GRAIL on 10 of the 13 factors compared between the two stocks.

How does Omada Health compare to LifeStance Health Group?

Omada Health (NASDAQ:OMDA) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

LifeStance Health Group has a net margin of 1.55% compared to Omada Health's net margin of -2.22%. LifeStance Health Group's return on equity of 1.56% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
LifeStance Health Group	1.55%	1.56%	1.07%

85.5% of LifeStance Health Group shares are owned by institutional investors. 6.4% of Omada Health shares are owned by company insiders. Comparatively, 3.2% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, LifeStance Health Group had 2 more articles in the media than Omada Health. MarketBeat recorded 4 mentions for LifeStance Health Group and 2 mentions for Omada Health. Omada Health's average media sentiment score of 1.25 beat LifeStance Health Group's score of 0.96 indicating that Omada Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	4.16	-$12.78M	-$0.27	N/A
LifeStance Health Group	$1.42B	2.08	$9.66M	$0.06	127.33

Omada Health presently has a consensus price target of $22.91, indicating a potential upside of 25.81%. LifeStance Health Group has a consensus price target of $9.86, indicating a potential upside of 29.02%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, analysts plainly believe LifeStance Health Group is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
LifeStance Health Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

LifeStance Health Group beats Omada Health on 12 of the 16 factors compared between the two stocks.

Get Omada Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OMDA vs. The Competition

Export

Metric	Omada Health	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.03B	$8.52B	$6.30B	$12.43B
Dividend Yield	N/A	1.80%	2.69%	5.33%
P/E Ratio	-67.44	22.90	23.78	24.34
Price / Sales	4.16	22.10	532.69	115.17
Price / Cash	N/A	88.38	41.39	55.53
Price / Book	4.59	5.92	10.04	6.72
Net Income	-$12.78M	$178.24M	$3.56B	$337.03M
7 Day Performance	1.34%	-1.06%	-0.99%	-0.13%
1 Month Performance	16.36%	8.96%	2.25%	3.76%
1 Year Performance	N/A	6.09%	29.11%	34.36%

Omada Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OMDA Omada Health	3.3682 of 5 stars	$18.21 +5.1%	$22.91 +25.8%	N/A	$1.03B	$260.21M	N/A	849	Positive News
VCYT Veracyte	1.6872 of 5 stars	$48.18 +4.0%	$46.33 -3.8%	+83.0%	$3.70B	$541.74M	44.20	790	Trending News Analyst Forecast Insider Trade
OPCH Option Care Health	4.8206 of 5 stars	$20.46 -2.0%	$31.25 +52.7%	-35.9%	$3.28B	$5.67B	15.86	8,266	Positive News
CON Concentra Group Holdings Parent	4.5859 of 5 stars	$25.28 +1.6%	$30.25 +19.7%	+15.8%	$3.18B	$2.23B	18.19	13,133	Positive News Insider Trade
GRAL GRAIL	1.0798 of 5 stars	$64.40 -10.2%	$67.88 +5.4%	+66.3%	$3.08B	$147.17M	N/A	1,360	Analyst Forecast Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OMDA) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Omada Health (OMDA) Competitors

OMDA vs. VCYT, OPCH, CON, GRAL, and LFST

How does Omada Health compare to Veracyte?

Summary

How does Omada Health compare to Option Care Health?

Summary

How does Omada Health compare to Concentra Group Holdings Parent?

Summary

How does Omada Health compare to GRAIL?

Summary

How does Omada Health compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMDA vs. The Competition

Omada Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Omada Health (OMDA) Competitors

OMDA vs. VCYT, OPCH, CON, GRAL, and LFST

How does Omada Health compare to Veracyte?

Does the media prefer VCYT or OMDA?

Which has better earnings & valuation, VCYT or OMDA?

Do analysts rate VCYT or OMDA?

Is VCYT or OMDA more profitable?

Summary

How does Omada Health compare to Option Care Health?

Which has stronger earnings & valuation, OMDA or OPCH?

Is OMDA or OPCH more profitable?

Does the media refer more to OMDA or OPCH?

Do insiders and institutionals have more ownership in OMDA or OPCH?

Do analysts prefer OMDA or OPCH?

Summary

How does Omada Health compare to Concentra Group Holdings Parent?

Is OMDA or CON more profitable?

Which has better valuation & earnings, OMDA or CON?

Do analysts prefer OMDA or CON?

Does the media prefer OMDA or CON?

Summary

How does Omada Health compare to GRAIL?

Do analysts prefer OMDA or GRAL?

Which has stronger earnings and valuation, OMDA or GRAL?

Is OMDA or GRAL more profitable?

Does the media prefer OMDA or GRAL?

Summary

How does Omada Health compare to LifeStance Health Group?

Is OMDA or LFST more profitable?

Do institutionals & insiders have more ownership in OMDA or LFST?

Does the media prefer OMDA or LFST?

Which has better valuation and earnings, OMDA or LFST?

Do analysts prefer OMDA or LFST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMDA vs. The Competition

Omada Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools